The additive effect of neurotransmitter genes in pathological gambling

Clinical Genetics

Volumn 60, Issue 2, 2001, Pages 107-116

  De Comings, ^a   Gade Andavolu, R ^a   Gonzalez, N ^a   Wu, S ^a   Muhleman, D ^a   Chen, C ^a   Koh, P ^a   Farwell, K ^a   Blake, H ^a   Dietz, G ^a   MacMurray, J P ^b   Lesieur, H R ^c   Rugle, L J ^d   Rosenthal, R J ^e  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b LOMA LINDA UNIVERSITY   (United States)

^c Department of Criminal Justice Sciences Illinois State ^*  (United States)

^d Trimeridian Inc   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Behavior; Dopamine; Gambling; Multifactorial; Norepinephrine; Polygenic; Psychiatric; Serotonin

Indexed keywords

4 AMINOBUTYRIC ACID; ALPHA 2C ADRENERGIC RECEPTOR; DNA; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTRANSMITTER; NORADRENALIN; SEROTONIN; TRYPTOPHAN HYDROXYLASE;

ADDICTION; ADULT; AGE; ARTICLE; BRAIN FUNCTION; CLINICAL GENETICS; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC ANALYSIS; GENETIC CODE; GENETIC RISK; GENOTYPE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATHOLOGICAL GAMBLING; PRIORITY JOURNAL; RACE DIFFERENCE; REGRESSION ANALYSIS; RISK ASSESSMENT; SEX DIFFERENCE; TREATMENT PLANNING;

ADULT; FEMALE; GAMBLING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUROTRANSMITTER AGENTS; RECEPTORS, ADRENERGIC; RECEPTORS, DOPAMINE; RECEPTORS, GABA; RECEPTORS, SEROTONIN; SUBSTANCE-RELATED DISORDERS;

EID: 0034874971     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.2001.600204.x     Document Type: Article

References (77)

1. A comparison of pathological gamblers to alcoholics and cocaine misusers on impulsivity, sensation seeking, and craving
2. The Chase: Career of the Compulsive Gambler
3. Pathological gambling among youthful multiple substance abusers in a therapeutic community
4. Commonalities in Substance Abuse and Habitual Behaviors
5. The Addictive Behaviors
6. Varieties of pathological gambling
7. Pathological gambling
8. Self-reported withdrawal symptoms and pathological gambling
9. Cessation of high frequency gambling and 'withdrawal' symptoms
10. The prevalence and demographics of pathological gamblers: Implications for public health
11. Prevalence of problem gambling: A replication study 7 years later
12. Pathological gambling and depression
13. Pathological gambling and major affective disorder: Preliminary findings
14. Pathological gambling and major affective disorder: Preliminary findings
15. Affective disorders among pathological gamblers seeking treatment
16. Alcoholism, drug abuse and gambling
17. Patterns of substance abuse in pathological gamblers undergoing treatment
18. Comorbidity of pathological gambling in addiction treatment facilities
19. Behavioral restraint and symptoms of attention deficit disorder in alcoholics and pathological gamblers
20. Attention deficit disorder and pathological gambling
21. Neuropsychological assessment of attention problems in pathological gamblers
22. Impulse control disorders and attention deficit disorder in pathological gamblers
23. Crime, antisocial personality and pathological gambling
24. The pathological gambler's system of self-deception
25. The relationship between pathological gambling and narcissism
26. Taking chances: Problem gamblers and mental health disorders - Results form the St. Louis Epidemiological Catchment Area Study
27. Familial influences on problem gambling: An analysis of 3,359 twin pairs
28. A twin study of adult gambling behavior
29. A study of the dopamine D2 receptor gene in pathological gambling
30. Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors
31. Studies of the 48 bp repeat of the DRD4 gene in impulsive-addictive behaviors: Tourette syndrome, ADHD, pathological gambling, and substance abuse
32. Genetic association study between pathological gambling and a functional DNA polymorphism at the D4 receptor gene
33. Exon and intron mutations in the human tryptophan 2,3-dioxygenase gene and their potential association with Tourette syndrome, substance abuse and other psychiatric disorders
34. Low platelet monoamine oxidase activity in pathological gambling
35. Altered dopamine function in pathological gambling
36. Diagnosis, neurobiology, and treatment of pathological gambling
37. Plasma endorphin levels in pathological gambling
38. Comparison of the role of dopamine, serotonin, and noradrenergic genes in ADHD, ODD and conduct disorder. Multivariate regression analysis of 20 genes
39. A multivariate analysis of 59 candidate genes in personality traits: The Temperament Character Inventory
40. Multivariate analysis of associations of 42 genes in ADHD, ODD and conduct disorder
41. Tourette Syndrome and Human Behavior
42. National Institute of Health diagnostic interview schedule
43. Polygenic inheritance and micro/minisatelites
44. The INS 5′ variable number of tandem repeats is associated with IGF2 expression in humans
45. Molecular heterosis: A review
46. Identification of a cys-ser substitution in the 5-HT2C (htr2C) receptor gene and allelic association to violent behavior and alcoholism
47. Dinucleotide repeat polymorphism in human X-linked GABA-A receptor alpha3-subunit gene
48. Association of the androgen receptor gene (AR) with ADHD and conduct disorder
49. Characterization of a highly polymorphic region near the first exon of the human MAOA gene containing a GT dinucleotide and a novel VNTR motif
50. Searching for genetic determinants in the new millennium
51. Polygenetic inheritance of psychiatric disorders
52. Why different rules are required for polygenic inheritance: Lessons from studies of the DRD2 gene
53. Meta-analysis of the association between the dopamine D4 gene 7-repeat and attention deficit hyperactivity disorder
54. Population and familial association between the D4 dopamine receptor gene and measures of novelty seeking
55. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder
56. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats
57. The reward system of the brain
58. Brain dopamine and reward
59. Evidence for striatal dopamine release during a video game
60. Reward deficiency syndrome
61. Allelic association of the D2 dopamine receptor gene with receptor- binding characteristics in alcoholism
62. Molecular heterosis as the explanation for the controversy about the effect of the DRD2 gene on dopamine D2 receptor density
63. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers
64. D2 dopamine receptor polymorphism and brain regional glucose metabolism
65. Suicidal behavior and the tryptohan hydroxylase gene
66. Suicidality and 5-hydroxyindoleacetic acid concentration associated with a tryptophan hydrolylase polymorphism
67. A tryptophan hydroxylase gene marker for suicidality and alcoholism
68. Extraversion in pathological gamblers. Correlates with indexes of noradrenergic function
69. Haplotype relative risk study of catechol-O-methytransferase (COMT) and attention deficit hyperactivity disorder (ADHD): Association of the high-enzyme activity Val allele with ADHD impulsive-hyperactive phenotype
70. Association study between high and low activity polymorphism of catechol-O-methyltransferase gene and alcoholism
71. Association between the functional polymorphism of catechol-O-methyltransferase gene and alcohol consumption among social drinkers
72. Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism
73. CSF GABA and neuropeptides in pathological gamblers and normal controls
74. Phenemenology and outcome of subjects with early- and adult-onset psychotic mania
75. Pharmacologic approaches in the treatment of pathological gambling
76. Interventions for pathological gambling